Increased bone mineral density in a subset of patients with relapsed multiple myeloma who received the combination of bortezomib, dexamethasone and zoledronic acid
Increased bone mineral density in a subset of patients with relapsed multiple myeloma who received the combination of bortezomib, dexamethasone and zoledronic acid
Languages of Item:
English
Abstract:
Empty abstract
Publication year:
2009
Authors:
Terpos, E Christoulas, D Kokkoris, P Gavriatopoulou, M Boutsikas, G Migkou, M Anargyrou, K Kastritis, E Tsionos, K Dimopoulos, MA
